However, despite increases in TLR4 expression, it is a well‐established clinical observation that patients with AR are more prone to develop infections and have an increased need for antibiotics,1 validating the inability for SP to prime the immune response in allergy. The gene discussed is TLR4; the disease is allergic disease.